SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001725160-21-000240
Filing Date
2021-12-16
Accepted
2021-12-16 17:18:34
Documents
1
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163969309168141.html 4  
1 FORM 4 wf-form4_163969309168141.xml 4 16869
  Complete submission text file 0001725160-21-000240.txt   18435
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address
Gallagher Cam (Reporting) CIK: 0001557832 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39263 | Film No.: 211498557

Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Issuer) CIK: 0001725160 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations